clinical trials
A look at the clinical trial space and its many inefficiencies in need of disruption.
A new innovation center called the Biome and numerous internal efforts paint a picture of a digital-focused game plan.
Kamal Obbad, Co-founder and CEO of Nebula Genomics, is working to help consumers understand consent and the risks to consider before giving someone access to their data based on a blockchain model. Nebula Genomics was the winner of the 2018 Health 2.0 Launch! contest.